Titan Medical’s surgeon workstation
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Titan Medical (TMD) has received the United States Patent and Trademark Office (USPTO) user experience patent
  • The patent, with No. 11,504,191, is titled “Graphical User Interface for a Robotic Surgical System”
  • The patent is directed at enhancing the surgeon user experience and generally covers a graphical user interface (GUI) overlay of a surgical workspace to track instrument movement
  • Titan Medical Inc. is a medical device company focused on enhancing robotic-assisted surgery (RAS) using innovative technology through a single access point
  • Titan Medical Inc. was unchanged at C$0.92 at 1:02 PM ET

Titan Medical (TMD) has received the United States Patent and Trademark Office (USPTO) user experience patent.

The patent, with No. 11,504,191, is titled “Graphical User Interface for a Robotic Surgical System.”

The patent is directed at enhancing the surgeon user experience and generally covers a graphical user interface (GUI) overlay of a surgical workspace to track instrument movement.

“The granting of this patent is a result of our strategic plan to independently build and protect a robust patent portfolio in robotic-assisted surgery, including around the Enos robotic single access surgical system,” noted Cary Vance, President and CEO of Titan.

“Along with recent patent application filings, including some that have recently been published, this patent demonstrates the company’s focus on being an innovation leader in single-access RAS,” he added.

The granted patent covers technology that generates a three-dimensional boundary for instruments within the surgical workspace based on movement generated by a user-controlled hand controller.

It also covers technology that provides the surgeon user with the ability to limit instrument movement based on a two-dimensional projection of the instrument’s position on the surgeon’s screen based on visual data as well as pre-operative patient imaging or scans or other patient-specific data embodying one or more keep-out zones.

Titan has developed an expansive intellectual property portfolio with over 225 pending and issued patents covering the United States and other jurisdictions.

This coverage may provide the company with multiple intellectual property options, including further protecting its RAS technologies and the potential to further license its technologies and secure strategic options.

Titan Medical Inc. is a medical device company headquartered in Toronto, Ontario, with operations in Chapel Hill, North Carolina, focused on enhancing robotic-assisted surgery (RAS) using innovative technology through a single access point.

Titan Medical Inc. was unchanged at C$0.92 at 1:02 PM ET.


More From The Market Herald

" @ the Bell: Growth-sensitive stocks fluctuate on mega jobs report

Canada’s main stock index ended on the higher side of flat on Friday trading as strength in the energy and technology sectors was weighed against

" Aimia (TSX:AIM) sells $7.36M in shares to Mithaq Capital

Aimia (AIM) has sold approximately $7.36 million of its common shares to investor company Mithaq Capital SPC.

" Terra Firma Capital (TSXV:TII) appoints new board member

Terra Firma Capital (TII) appoints Mike Kirchmair as a member of the corporation’s board of directors.
Capital Power Corporation - The Whitla Wind Facility

" Capital Power (TSX:CPX) looks forward to protecting the environment

Capital Power Corporation (CPX) enters a 23-year clean electricity supply agreement with Public Services and Procurement Canada to protect the environment.